Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 2015

View Archived Issues

World Glaucoma Week: Novel agent is beneficial in model of intraocular hypertension

Northeastern University patents CB1 receptor modulators

CureVac patent describes antiviral combination vaccines

LG Life Sciences discloses necrosis and apoptosis inhibitors

Bioavailability studies support marketing applications for Bekinda

Taiho Pharmaceutical reports development of BTK inhibitors

FGFR and steroid hormone receptors could serve as thyroid cancer biomarkers

BMS-938790, a PEG-adnectin targeting hIL-23, for treatment of inflammatory diseases

SNP in TRMT11 gene described as potential biomarker in advanced-stage CRPC

Interleukin Genetics to provide genomic testing service for Isis phase I trial

University of Toronto divulges new anti-Frizzled antibodies

Bayer submits MAA for aflibercept for myopic choroidal neovascularization

Rotavac vaccine launched in India

Hua Medicine files IND in U.S. for HMS-5552

Alcobra's MDX meets primary endpoint in phase II trial in ADHD

Phase II trial of TKM-Ebola-Guinea starts in Sierra Leone

Dimethandrolone shows potential for male contraception

InMed Pharmaceuticals and University of Debrecen to develop cannabinoids for ocular allergy

Celgene gains access to Open Monoclonal Technology's OmniAb platform

Therapure cleared to begin phase I trial of TBI-304H for chemotherapy-induced anemia

Collegium raises financing to advance Xtampza ER to launch

Antibe Therapeutics resumes development of ATB-346 following review of phase I data

Zogenix sells Zohydro ER extended-release hydrocodone to Pernix Therapeutics

University of Tokyo and Sanofi collaborate in inflammatory diseases and oncology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...